Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA) as Reportable Conditions in Wisconsin

This memo provides updated guidance for reporting VISA/VRSA in Wisconsin: In alignment with current reporting guidelines for other multidrug-resistant organisms (MDROs), VISA/VRSA shall be considered a Category II reportable condition in Wisconsin.